Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2007 1
2008 1
2011 1
2012 1
2013 3
2014 4
2015 6
2016 5
2017 5
2018 4
2019 5
2020 6
2021 7
2022 4
2023 2
2024 7
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean paola ferretti (1 results)?
Follow-up of early breast cancer in a public health system: A 2024 AIGOM consensus project.
Gori S, De Rose F, Ferro A, Fabi A, Angiolini C, Azzarello G, Cancian M, Cinquini M, Arecco L, Aristei C, Bernardi D, Biganzoli L, Cariello A, Cortesi L, Cretella E, Criscitiello C, De Giorgi U, Carmen De Santis M, Deledda G, Dessena M, Donati S, Dri A, Ferretti G, Foglietta J, Franceschini D, Franco P, Schirone A, Generali D, Gianni L, Giordani S, Grandi G, Cristina Leonardi M, Magno S, Malorni L, Mantoan C, Martorana F, Meattini I, Meduri B, Merlini L, Miglietta F, Modena A, Nicolis F, Palumbo I, Panizza P, Angela Rovera F, Salvini P, Santoro A, Taffurelli M, Toss A, Tralongo P, Turazza M, Valerio M, Verzè M, Vici P, Zamagni C, Curigliano G, Pappagallo G, Zambelli A; Italian Association of Multidisciplinary Oncology Groups (AIGOM). Gori S, et al. Cancer Treat Rev. 2024 Dec;131:102832. doi: 10.1016/j.ctrv.2024.102832. Epub 2024 Oct 5. Cancer Treat Rev. 2024. PMID: 39437511 Free article. Review.
Limiting factors to oxygen transport on Mount Everest 30 years after: a critique of Paolo Cerretelli's contribution to the study of altitude physiology.
Ferretti G. Ferretti G. Eur J Appl Physiol. 2003 Oct;90(3-4):344-50. doi: 10.1007/s00421-003-0923-2. Epub 2003 Oct 3. Eur J Appl Physiol. 2003. PMID: 14530980 Review.
In 1976, Paolo Cerretelli published an article entitled "Limiting factors to oxygen transport on Mount Everest" in the Journal of Applied Physiology. ...
In 1976, Paolo Cerretelli published an article entitled "Limiting factors to oxygen transport on Mount Everest" in the Journal of App …
Protective ileostomy creation after anterior resection of the rectum (PICARR): a decision-making exploring international survey.
Balla A, Saraceno F, Rullo M, Morales-Conde S, Targarona Soler EM, Di Saverio S, Guerrieri M, Lepiane P, Di Lorenzo N, Adamina M, Alarcón I, Arezzo A, Bollo Rodriguez J, Boni L, Biondo S, Carrano FM, Chand M, Jenkins JT, Davies J, Delgado Rivilla S, Delrio P, Elmore U, Espin-Basany E, Fichera A, Lorente BF, Francis N, Gómez Ruiz M, Hahnloser D, Licardie E, Martinez C, Ortenzi M, Panis Y, Pastor Idoate C, Paganini AM, Pera M, Perinotti R, Popowich DA, Rockall T, Rosati R, Sartori A, Scoglio D, Shalaby M, Simó Fernández V, Smart NJ, Spinelli A, Sylla P, Tanis PJ, Valdes Hernandez J, Wexner SD, Sileri P; Protective Ileostomy Creation after Anterior Resection of the Rectum (PICARR) Collaborative Group. Balla A, et al. Updates Surg. 2025 Mar 23. doi: 10.1007/s13304-025-02111-6. Online ahead of print. Updates Surg. 2025. PMID: 40121358
External validation of a nomogram for outcome prediction in management of medium-sized (1-2 cm) kidney stones.
Sighinolfi MC, Calcagnile T, Ticonosco M, Kaleci S, DI Bari S, Assumma S, Sarchi L, Panio E, Ferrari R, Piro A, Ragusa A, Ciarlariello S, DA Silva RD, LA Rocca R, Illiano E, Paladini A, Persico F, Giraudo D, DE Marzo E, Grisanti R, Mantica G, Emiliani E, Madonia M, Salvetti M, Bassi P, Montanari E, Bove P, Simonato A, Averch TD, Porpiglia F, Calarco A, Bruschetta S, Manferrari F, Daels FP, Cerruto MA, Antonelli A, Mazzon G, Celia A, Simeone C, Zaramella S, Saita A, Costantini E, Mearini E, DE Dominicis M, Mirone V, Kim FJ, Ferretti S, Puliatti S, Rocco B, Micali S. Sighinolfi MC, et al. Minerva Urol Nephrol. 2024 Aug;76(4):484-490. doi: 10.23736/S2724-6051.24.05672-6. Epub 2024 May 10. Minerva Urol Nephrol. 2024. PMID: 38727672 Free article.
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective, real-world experience with 200 cases outside of controlled clinical trials.
Gentile M, Vigna E, Palmieri S, Galli M, Derudas D, Mina R, Della Pepa R, Zambello R, Martino EA, Bruzzese A, Mangiacavalli S, Zamagni E, Califano C, Musso M, Conticello C, Cerchione C, Mele G, Di Renzo N, Offidani M, Tarantini G, Casaluci GM, Rago A, Ria R, Uccello G, Barilà G, Palumbo G, Pompa A, Vincelli D, Brunori M, Accardi F, Amico V, Amendola A, Fontana R, Bongarzoni V, Rossini B, Cotzia E, Gozzetti A, Rizzi R, Sgherza N, Ferretti E, Bertuglia G, Nappi D, Petrucci MT, Di Raimondo F, Neri A, Morabito F, Musto P. Gentile M, et al. Haematologica. 2024 Jan 1;109(1):245-255. doi: 10.3324/haematol.2023.283251. Haematologica. 2024. PMID: 37439329 Free PMC article.
Prognostic Significance of +1q Alterations in Relapsed/Refractory Multiple Myeloma Treated With Daratumumab-, Elotuzumab-, and Carfilzomib-Based Triplet Regimens: A Multicenter Real-World Analysis of 635 Patients.
Morabito F, Martino EA, Galli M, Offidani M, Zambello R, Bringhen S, Giuliani N, Califano C, Brunori M, Gagliardi A, Sgherza N, Quinto AM, Barilà G, Belotti A, Cerchione C, Casaluci GM, Fontana R, Bongarzoni V, Tarantini G, Derudas D, Patriarca F, Gozzetti A, Sementa A, Antonioli E, Rago A, Lotti F, De Magistris C, Petrucci MT, Pettine L, Bolli N, Conticello C, Zamagni E, Palmieri S, Musso M, Mele A, Della Pepa R, Vigna E, Bruzzese A, Fazio F, Mina R, Paris L, Vincelli ID, Farina G, Cangialosi C, Mancuso K, Falcone AP, Mele G, Sica A, Morè S, Reddiconto G, Tripepi G, D'Arrigo G, Barbieri E, Quaresima M, Cartia CS, Pezzatti S, Marcatti M, Farina F, Cafro A, Palumbo M, Masoni V, Ferretti VV, Di Raimondo F, Musto P, Neri A, Mangiacavalli S, Gentile M. Morabito F, et al. Eur J Haematol. 2025 Mar 19. doi: 10.1111/ejh.14413. Online ahead of print. Eur J Haematol. 2025. PMID: 40103518
Organizational impact of systemic implementation of digital breast tomosynthesis as a primary test for breast cancer screening in Italy.
Djuric O, Deandrea S, Mantellini P, Sardanelli F, Venturelli F, Montemezzi S, Vecchio R, Bucchi L, Senore C, Giordano L, Paci E, Bonifacino A, Calabrese M, Caumo F, Degrassi F, Sassoli De' Bianchi P, Battisti F, Zappa M, Pattacini P, Campari C, Nitrosi A, Di Leo G, Frigerio A, Magni V, Fornasa F, Romanucci G, Falini P, Auzzi N, Armaroli P, Giorgi Rossi P; MAITA working group; Italian Breast Cancer Screening Guidelines working group. Djuric O, et al. Radiol Med. 2024 Aug;129(8):1156-1172. doi: 10.1007/s11547-024-01849-0. Epub 2024 Jul 23. Radiol Med. 2024. PMID: 39042203
Validation of a new optical diagnosis training module to improve dysplasia characterization in inflammatory bowel disease: a multicenter international study.
Iacucci M, Bonovas S, Bazarova A, Cannatelli R, Ingram RJM, Labarile N, Nardone OM, Parigi TL, Piovani D, Siau K, Smith SCL, Zammarchi I, Ferraz JGP, Fiorino G, Kiesslich R, Panaccione R, Parra-Blanco A, Principi M, Tontini GE, Uraoka T, Ghosh S; OPTIC-IBD Study Group. Iacucci M, et al. Gastrointest Endosc. 2024 May;99(5):756-766.e4. doi: 10.1016/j.gie.2023.11.018. Epub 2023 Nov 21. Gastrointest Endosc. 2024. PMID: 37993058 Free article. Clinical Trial.
54 results